Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sensus Healthcare (SRTS) Receivables (2016 - 2026)

Sensus Healthcare has reported Receivables over the past 11 years, most recently at $6.0 million for Q4 2025.

  • For Q4 2025, Receivables fell 69.38% year-over-year to $6.0 million; the TTM value through Dec 2025 reached $6.0 million, down 69.38%, while the annual FY2025 figure was $6.0 million, 69.38% down from the prior year.
  • Receivables for Q4 2025 was $6.0 million at Sensus Healthcare, down from $9.3 million in the prior quarter.
  • Over five years, Receivables peaked at $19.7 million in Q4 2024 and troughed at $4.1 million in Q1 2021.
  • A 5-year average of $11.5 million and a median of $10.6 million in 2022 define the central range for Receivables.
  • Biggest five-year swings in Receivables: surged 321.54% in 2021 and later tumbled 69.38% in 2025.
  • Year by year, Receivables stood at $12.1 million in 2021, then surged by 42.61% to $17.3 million in 2022, then crashed by 38.46% to $10.6 million in 2023, then soared by 85.35% to $19.7 million in 2024, then tumbled by 69.38% to $6.0 million in 2025.
  • Business Quant data shows Receivables for SRTS at $6.0 million in Q4 2025, $9.3 million in Q3 2025, and $12.6 million in Q2 2025.